John H. Wilton
Impact in
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
- Virology top 5%
- HIV Research and Treatment
Papers in
- Pharmacology 24
- Antibiotics Pharmacokinetics and Efficacy 17
- Oncology 9
- Co-authors
- Jerome J. Schentag (9 shared papers)David E. Nix (10 shared papers)David E. Martin (2 shared papers)Alan Forrest (3 shared papers)Robert A. Blum (2 shared papers)James Lloyd Mohler (8 shared papers)Graham P. Allaway (1 shared paper)Karl Salzwedel (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (10 papers)The Journal of Clinical Pharmacology (6 papers)The Journal of Antibiotics (4 papers)The Prostate (3 papers)The Journal of Organic Chemistry (3 papers)
- Partner nations
- United StatesCanadaChile
In The Last Decade
John H. Wilton
54 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 102
- Pharmacology 468
- Virology 107
- Molecular Medicine 102
- Pharmacology 148
- Pharmaceutical Science 90
Countries citing papers authored by John H. Wilton
This map shows the geographic impact of John H. Wilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Wilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Wilton more than expected).
Fields of papers citing papers by John H. Wilton
This network shows the impact of papers produced by John H. Wilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Wilton. The network helps show where John H. Wilton may publish in the future.
Co-authors
The 25 scholars most cited alongside John H. Wilton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 167 | |
| 2 | 1991 | 153 | |
| 3 | 1989 | 92 | |
| 4 | 1989 | 88 | |
| 5 | 1990 | 83 | |
| 6 | 1991 | 83 | |
| 7 | 2002 | 65 | |
| 8 | 2007 | 63 | |
| 9 | 2019 | 55 | |
| 10 | 2020 | 53 | |
| 11 | 1995 | 41 | |
| 12 | 2013 | 36 | |
| 13 | 1980 | 34 | |
| 14 | 1985 | 33 | |
| 15 | 2014 | 33 | |
| 16 | 2020 | 26 | |
| 17 | 1997 | 25 | |
| 18 | 1999 | 25 | |
| 19 | 2018 | 25 | |
| 20 | 1985 | 24 |
About John H. Wilton
John H. Wilton is a scholar working on Pharmacology, Oncology, Pulmonary and Respiratory Medicine, Molecular Medicine and Toxicology, having authored 56 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Prostate Cancer Treatment and Research (7 papers), Analytical Methods in Pharmaceuticals (4 papers), Pneumonia and Respiratory Infections (4 papers), Antibiotic Resistance in Bacteria (4 papers), Estrogen and related hormone effects (3 papers), Epilepsy research and treatment (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Pharmacology (468 citations), Virology (107 citations), Molecular Medicine (102 citations), Pharmacology (148 citations) and Pharmaceutical Science (90 citations). John H. Wilton has collaborated with scholars based in United States, Canada and Chile. Frequent co-authors include Jerome J. Schentag, David E. Nix, David E. Martin, Alan Forrest, Robert A. Blum, James Lloyd Mohler, Graham P. Allaway, Karl Salzwedel, Patrick F. Smith and James C. French. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Clinical Pharmacology, The Journal of Antibiotics, The Prostate and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.